Fig. 4From: Artificial intelligence-driven new drug discovery targeting serine/threonine kinase 33 for cancer treatmentMechanism of action associated with a new STK33 inhibitor, Z29077885. A Cell cycle assay for anti-cancer efficacy of Z29077885 in MDA-MB-231 and A549 cell lines at 50 uM and 100 uM was measured by PI flow cytometry. B Cell cycle assay for the effect of BRD-8899 and ML-281 in MDA-MB-231 and A549 cell lines at 50 uM was measured by PI flow cytometryBack to article page